pPKCα mediated-HIF-1α activation related to the morphological modifications occurring in neonatal myocardial tissue

S Zara1, V Macchi, R De Caro

  • 1Section of Human Anatomy, Faculty of Pharmacy, University G. d’Annunzio Chieti-Pescara, via dei Vestini 31, 66100 Chieti, Italy. s.zara@unich.it

Insights

High oxygen exposure in newborn rats triggers heart injury via a PKC-mediated HIF-1α pathway, impacting blood vessel growth and apoptosis due to immature antioxidant defenses.

Area of Science:

  • Cardiovascular Physiology
  • Neonatal Medicine
  • Molecular Biology

Background:

  • Neonatal hyperoxia can impair myocardial function due to free radical release, contrasting with protective effects in adult animals.
  • Age-dependent differences exist in the mechanisms and consequences of hyperoxia exposure on the heart.

Purpose of the Study:

  • To investigate the role of hypoxia-inducible factor-1α (HIF-1α) in hyperoxia-induced morphological changes in neonatal rat hearts.
  • To explore the signaling pathways, including PKC and NOS, involved in neonatal hyperoxia response.

Main Methods:

  • Exposure of neonatal rats to 95% oxygen.
  • Analysis of HIF-1α translocation and VEGF expression.
  • Assessment of PKC-α, e-NOS, and i-NOS expression.
  • Evaluation of apoptotic events using TUNEL and Bax expression.

Main Results:

  • Hyperoxia increased connective tissue and blood vessel growth, associated with elevated HIF-1α and VEGF.
  • PKC-α expression increased, suggesting its involvement in HIF-1α activation.
  • e-NOS expression decreased, while i-NOS expression increased, correlating with vasoconstriction and apoptosis.
  • Apoptotic events were more pronounced under severe hyperoxia.

Conclusions:

  • Neonatal hyperoxia can induce free radical-mediated injury via a PKCα-mediated HIF-1α signaling system.
  • This pathway influences both blood vessel development and pro-apoptotic events in immature hearts.
  • Specific inhibitors of PKCα may offer targeted interventions for hyperoxia-induced damage.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: